Chiron Capital Management, LLC Gilead Sciences, Inc. Transaction History

Chiron Capital Management, LLC

$103 Million
Q2 2024

A detailed history of Chiron Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chiron Capital Management, LLC holds 37,275 shares of GILD stock, worth $3.16 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares

37,275

Previous 19,571 90.46%

Holding current value

$3.16 Million

Previous $1.43 Million 78.44%

% of portfolio

2.48%

Previous 1.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $1.12 Million - $1.29 Million	17,704 Added 90.46%	37,275 $2.56 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $450,309 - $549,141	6,291 Added 47.37%	19,571 $1.43 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $212,336 - $240,794	-2,898 Reduced 17.91%	13,280 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $110,910 - $121,005	-1,500 Reduced 8.49%	16,178 $1.21 Million
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $448,459 - $511,530	-5,900 Reduced 25.02%	17,678 $1.36 Million
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $1.29 Million - $1.47 Million	-16,712 Reduced 41.48%	23,578 $1.96 Million
Q4 2022 Jan 23, 2023	SELL	$62.32 - $89.47 $3.85 Million - $5.53 Million	-61,840 Reduced 60.55%	40,290 $0
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $62,397 - $71,274	-1,048 Reduced 1.02%	102,130 $6.3 Million
Q2 2022 Jul 25, 2022	BUY	$57.72 - $65.01 $314,631 - $354,369	5,451 Added 5.58%	103,178 $6.38 Million
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $582,269 - $729,646	10,053 Added 11.47%	97,727 $5.81 Million
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $458,571 - $520,487	-7,068 Reduced 7.46%	87,674 $6.37 Million
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $1.66 Million - $1.79 Million	-24,464 Reduced 20.52%	94,742 $6.62 Million
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $291,263 - $318,247	-4,589 Reduced 3.71%	119,206 $8.21 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $183,600 - $209,487	-3,060 Reduced 2.41%	123,795 $8 Million
Q4 2020 Mar 05, 2021	SELL	$56.65 - $64.55 $105,538 - $120,256	-1,863 Reduced 1.45%	126,855 $7.39 Million
Q3 2020 Nov 19, 2020	BUY	$62.1 - $78.08 $7.99 Million - $10.1 Million	128,718 New	128,718 $8.13 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.

Account

Chiron Capital Management, LLC Gilead Sciences, Inc. Transaction History